Catalyst Wire Dossier Catalyst Wire Dossier

Combigan Ophthalmic Solution

Brimonidine; Timolol · Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Combigan Ophthalmic Solution, covering 2007-03-01 to 2007-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy [Phase 4]

See pricing